))
S11 E01 ASCO 2025: What's New for MBC?
Manage episode 512353245 series 2977267
Content provided by SHARE Cancer Support. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SHARE Cancer Support or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In our Season 11 opening episode, we’re bringing you the latest updates from the 2025 ASCO Annual Meeting on metastatic breast cancer. Dr. Ashley Schreier, breast oncologist at Weill Cornell Medicine, breaks down key research and explains what it could mean for people living with MBC.
Topics include:
- Research results for hormone therapy options like camizestrant
- The role of ESR1 mutation testing
- Results from treatment combinations like Enhertu and Perjeta, and Trodelvy and Keytruda
- How to navigate clinical trial access
- Tips for staying hopeful while exploring treatment options
Whether you’re a patient, caregiver, or advocate, this episode is packed with insights to help you stay informed and empowered.
166 episodes
Share
